NASDAQ

Adial Pharmaceuticals, Inc (ADIL)

♥ 627 Thanks from members

Live price chart, market sentiment, and community perspectives for Adial Pharmaceuticals, Inc (NASDAQ: ADIL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Murali K. GopalakrishnanLeadership: Kenneth Weinberger (CEO)Leadership: Cynthia Selin (CFO)Holder: Adial ManagementHolder: Institutional InvestorsHolder: Retail ShareholdersAD04 (Alcohol Use Disorder Treatment)Ondansetron Formulations#ADIL#Adial Pharmaceuticals#Biotech#AD04#Clinical Trials